Tag Archives: The Stem Cell Blog

Predictive Technology Group, Inc.’s (PRED) Subsidiary Provides a Sponsorship at 4th Annual Perinatal Stem Cell … – GlobeNewswire (press release)

Continue reading

2018-03-05 NEWS

GlobeNewswire (press release)

Predictive Technology Group, Inc.’s (PRED) Subsidiary Provides a Sponsorship at 4th Annual Perinatal Stem Cell
GlobeNewswire (press release)
Dr. Doug Schmid, Chief Science and Lab Officer, at Predictive Biotech, Inc. presented his topic during the March 1-2, 2018 4th Annual Perinatal Stem Cell Society Congress, Salt Lake City, UT, titled: “Wharton’s Jelly: A Perinatal Cytokine Reservoir

Continue reading

2018-03-05 NEWS

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial
GlobeNewswire (press release)
CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the eighth

Continue reading

2018-03-05 NEWS

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial
Nasdaq
CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the eighth

and more »

Continue reading

2018-03-05 NEWS

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial
Nasdaq
CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the eighth

and more »

Continue reading

2018-03-05 NEWS

Genetic Literacy Project

Targeted evolution: Why are we so afraid of CRISPR gene editing?
Genetic Literacy Project
The potential applications of CRISPR are enormous. It’s the closest we’ve ever come to a cure for cancer. We’ve already been able to cure HIV infection in animal models, and even in human cell cultures, by removing the viral genes that insert